CommercialCoverageMedium impact
08.01.83d, Tisotumab vedotin-tftv (Tivdak®)
Independence Blue Cross·Oncology·Pharmacy
Effective date
Jun 16, 2025
We identified it
Jun 19, 2026
Summary
Insurance policy for Tisotumab vedotin-tftv (Tivdak®) has been updated with changes to medical necessity criteria, medical coding requirements, and general guidelines. This affects how the oncology drug will be billed and what documentation is required for coverage approval.
Action Required
By June 16, 2025: Billing team must review updated medical necessity criteria and coding requirements for Tisotumab vedotin-tftv (Tivdak®). Access the full policy details at the provided URL to understand specific documentation requirements and billing guidelines. Update billing procedures accordingly to ensure claims compliance.